Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932471-24-000300
Filing Date
2024-11-04
Accepted
2024-11-04 11:18:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 UnitedStates_13G__CullinanTh.txt SC 13G/A 4050
  Complete submission text file 0000932471-24-000300.txt   5902
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Subject) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91966 | Film No.: 241421443
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)